| 1 |
Low molecular weight heparin |
Drug Class Review |
01 May 2016 |
Cardiovascular Health |
Research Summary |
| 2 |
The influence of socioeconomic status on selection of anticoagulation for atrial fibrillation |
Journal Article |
25 Feb 2016 |
Cardiovascular Health |
|
| 3 |
Impact of the JUPITER trial on statin prescribing for primary prevention |
Journal Article |
12 Aug 2013 |
Cardiovascular Health |
|
| 4 |
Trends in the coprescription of proton pump inhibitors with clopidogrel: An ecological analysis |
Journal Article |
26 Nov 2015 |
Cardiovascular Health |
|
| 5 |
Antipsychotics in the elderly |
Drug Class Review |
01 May 2015 |
Dementia and Antipsychotics |
Research Summary |
| 6 |
Cognitive enhancers for Alzheimer's Disease |
Drug Class Review |
01 Aug 2015 |
Dementia and Antipsychotics |
Research Summary |
| 7 |
Association of a blood glucose test strip quantity-limit policy with patient outcomes: A population-based study |
Journal Article |
07 Nov 2016 |
Diabetes |
Research Minute |
| 8 |
Adherence to prescribing recommendations made on a provincial formulary |
Journal Article |
01 May 2014 |
Diabetes |
Research Minute |
| 9 |
Blood glucose test strips: Options to reduce usage |
Journal Article |
12 Jan 2010 |
Diabetes |
Letter to Editor |
| 10 |
The impact of policies to reduce blood glucose test strip utilization and costs in Canada |
Journal Article |
01 Jun 2015 |
Diabetes |
Research Minute |
| 11 |
Self-monitoring of blood glucose levels: Evaluating the impact of a policy of quantity limits on test-strip use and costs |
Journal Article |
17 May 2016 |
Diabetes |
Research Minute |
| 12 |
Self-monitoring of blood glucose: Impact of quantity limits in public drug formularies on provincial costs across Canada |
Journal Article |
15 Dec 2016 |
Diabetes |
|
| 13 |
Self-monitoring of blood glucose: Patterns costs and potential cost reduction associated with reduced testing |
Public Report |
01 Dec 2009 |
Diabetes |
|
| 14 |
Professional pharmacy services and patient complexity: An observational study |
Journal Article |
03 Dec 2015 |
Drug Policy |
Research Minute |
| 15 |
Sevelamer prescriptions after reporting of the dialysis clinical outcomes revisited (DCOR) trial findings: An analysis of 5 495 patients receiving maintenance dialysis in Ontario, Canada |
Letter to Editor |
18 Jan 2011 |
Kidney Disease |
|
| 16 |
Drugs for the management of attention-deficit/hyperactivity disorder |
Drug Class Review |
01 Dec 2015 |
Mental Health |
Research Summary |
| 17 |
Triptans for the management of acute episodic migraine |
Drug Class Review |
01 Mar 2014 |
Migraines |
Research Summary |
| 18 |
Public drug coverage and its impact on triptan use across Canada: A population-based study |
Journal Article |
07 Mar 2015 |
Migraines |
Drug Class Review |
| 19 |
Reformulation of controlled-release oxycodone and pharmacy dispensing patterns near the US–Canada border |
Journal Article |
13 Nov 2012 |
Opioids |
Research Minute |
| 20 |
Effect of a course-based intervention and effect of medical regulation on physicians’ opioid prescribing |
Journal Article |
01 May 2013 |
Opioids |
Research Minute |
| 21 |
Impact of legislation and a prescription monitoring program on the prevalence of potentially inappropriate prescriptions for monitored drugs in Ontario: A time series analysis |
Journal Article |
18 Nov 2014 |
Opioids |
Research Minute |
| 22 |
High strength opioid formulations in Ontario: By the numbers |
Public Report |
02 Aug 2016 |
Opioids |
Infographic |
| 23 |
Treatment for chronic Hepatitis B |
Drug Class Review |
01 Sep 2015 |
Other |
Research Summary |
| 24 |
Allergen immunotherapy |
Drug Class Review |
01 Oct 2015 |
Other |
Research Summary |
| 25 |
Effects of funding policy changes and health warnings on the use of erythropoiesis-stimulating agents |
Journal Article |
17 Jan 2012 |
Other |
|
